AU6524794A - Cloned receptors and methods for screening - Google Patents

Cloned receptors and methods for screening

Info

Publication number
AU6524794A
AU6524794A AU65247/94A AU6524794A AU6524794A AU 6524794 A AU6524794 A AU 6524794A AU 65247/94 A AU65247/94 A AU 65247/94A AU 6524794 A AU6524794 A AU 6524794A AU 6524794 A AU6524794 A AU 6524794A
Authority
AU
Australia
Prior art keywords
screening
methods
cloned receptors
cloned
receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65247/94A
Other languages
English (en)
Inventor
Keith Albrandt
Kevin Beaumont
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amylin Pharmaceuticals LLC
Original Assignee
Amylin Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals LLC filed Critical Amylin Pharmaceuticals LLC
Publication of AU6524794A publication Critical patent/AU6524794A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
AU65247/94A 1993-03-24 1994-03-24 Cloned receptors and methods for screening Abandoned AU6524794A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3678493A 1993-03-24 1993-03-24
US036784 1993-03-24
PCT/US1994/003248 WO1994021665A1 (fr) 1993-03-24 1994-03-24 Recepteurs clones et methodes de criblage associees

Publications (1)

Publication Number Publication Date
AU6524794A true AU6524794A (en) 1994-10-11

Family

ID=21890634

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65247/94A Abandoned AU6524794A (en) 1993-03-24 1994-03-24 Cloned receptors and methods for screening

Country Status (2)

Country Link
AU (1) AU6524794A (fr)
WO (1) WO1994021665A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0663006A1 (fr) * 1992-09-30 1995-07-19 Zymogenetics, Inc. Recepteur de la calcitonine humaine
WO1996031526A1 (fr) * 1995-04-06 1996-10-10 Amylin Pharmaceuticals, Inc. Agents antiobesite
WO2002057792A2 (fr) * 2000-12-29 2002-07-25 Neogenesis Pharmaceuticals, Inc. Criblage de proteines hydrophobes par selection d'affinites
CA2471833A1 (fr) * 2001-11-26 2003-06-05 Protemix Corporation Limited Procedes et compositions pour normaliser les niveaux lipidiques dans les tissus mammaliens
US8932208B2 (en) 2005-05-26 2015-01-13 Maquet Cardiovascular Llc Apparatus and methods for performing minimally-invasive surgical procedures
BRPI0618705B8 (pt) 2005-11-14 2021-05-25 Labrys Biologics Inc anticorpos antagonistas humanizados direcionados contra peptídeo relacionado ao gene da calcitonina, composição farmacêutica e uso dos mesmos
JP2010540160A (ja) 2007-10-05 2010-12-24 マッケ カーディオバスキュラー，エルエルシー 最小限に侵襲的な外科的処置のための装置および方法
CA2716424C (fr) 2008-03-04 2015-04-28 Pfizer Limited Procedes de traitement d'une douleur chronique
RU2535074C2 (ru) 2009-08-28 2014-12-10 Лэйбрис Байолоджикс, Инк. Способы лечения висцеральной боли путем введения антител-антагонистов, направленных против пептида, связанного с геном кальцитонина
EP3272769B1 (fr) 2012-01-26 2020-06-17 Christopher J. Soares Antagonistes peptidiques de la calcitonine cgrp de la famille des hormones peptidiques et leur utilisation
JP6538682B2 (ja) * 2013-07-30 2019-07-03 ソアレス クリストファー ジェイ． Ｃｇｒｐアゴニストペプチド
RS65360B1 (sr) 2014-03-21 2024-04-30 Teva Pharmaceuticals Int Gmbh Antagonistička antitela specifična za peptid genski srodan kalcitoninu i postupci njihove upotrebe
US10556945B2 (en) 2014-03-21 2020-02-11 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
WO2018045083A1 (fr) 2016-09-02 2018-03-08 Soares Christopher J Utilisation d'antagonistes du récepteur cgrp en neuroprotection et pour le traitement de troubles neurologiques
MX2019003337A (es) 2016-09-23 2019-09-26 Teva Pharmaceuticals Int Gmbh Tratamiento para migraña refractaria.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264372A (en) * 1991-03-15 1993-11-23 Amylin Pharmaceuticals, Inc. Receptor-based screening methods for amylin agonists and antagonists

Also Published As

Publication number Publication date
WO1994021665A1 (fr) 1994-09-29

Similar Documents

Publication Publication Date Title
AU5099493A (en) Method for generating and screening useful peptides
HU9400710D0 (en) 2-debenzoyl-2-acyl-taxol derivatives and methods for making same
AU6468196A (en) Grading machine and equipment
AU5979496A (en) Composition and methods for losing weight
AU7663596A (en) Materials and methods for controlling nematodes
AU6524794A (en) Cloned receptors and methods for screening
AU6856796A (en) Des-arg9-bk antagonists
AU677319B2 (en) Materials and methods for screening anti-osteoporosis agents
AU7289494A (en) Void grading
AU7081094A (en) Cell growth factor receptors
AU662683B2 (en) Screening arrangement
AU6750594A (en) Receptors of interleukin-12 and antibodies
EP0694078A4 (fr) Procede de triage concernant des agonistes de recepteurs
AU5413296A (en) Screening device
AU6263996A (en) Method for screening for receptor agonists and antagonists
AU2207195A (en) Modified receptors that continuously signal
AU6117794A (en) Optimal article grading system
AU7571194A (en) Azotobacterin and the method for preparing the same
AU4997493A (en) Improved cardiovascular patch materials and method for producing same
AU7858691A (en) Plaque-inhibiting protein from bacteroides loeschei and methods for using the same
AU8079094A (en) Anti-paramyxovirus screening method and vaccine
AU4472993A (en) Screening apparatus
AU7348796A (en) Screening arrangement
AU6361494A (en) Anhydroretinol and derivatives thereof as antagonists
AU4960393A (en) Sifter